|
1. |
Fluorescent Imaging of a Dual-Pathway Atrioventricular-Nodal Conduction System |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 23-30
Vladimir Nikolski,
Igor Efimov,
Preview
|
PDF (1547KB)
|
|
摘要:
Abstract—A dual-pathway theory to explain atrioventricular-nodal (AVN) reentry has been proposed previously. However, the exact anatomical and functional correlates of the fast pathway (FP) and slow pathway (SP) have not yet been elucidated. We used optical mapping to reconstruct patterns of activation during retrograde conduction through the AVN and during AVN reentry in the triangles of Koch of 12 rabbits. Reentry was inducible by a premature stimulation of the bundle of His in 6 preparations (50%). A functional FP and SP appear to be anatomically correlated with posterior and posterolateral extensions of the AVN, which were recently described. Retrograde breakthrough points in 6 noninducible preparations were clustered near the apex of the triangle of Koch (FP), whereas 6 inducible preparations had either cycle length–dependent FP and SP exits (n=3) or only SP exits located near the coronary sinus orifice. The shift of breakthrough points from FP to SP during progressive shortening of the coupling interval was accompanied by a discontinuity in the conduction curve. We observed a transmural reentrant circuit involving the AVN, FP, SP, and the superficial endocardial layer of atrial and transitional cells. The presence of a functional SP during retrograde conduction was associated with inducibility of AVN reentry. The full text of this article is available at http://www.circresaha.org.
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
2. |
Cardiovascular ResearchA Look Into Tomorrow |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 253-255
Claude Lenfant,
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
3. |
TRP ProteinsNovel Therapeutic Targets for Regional Blood Pressure Control? |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 256-259
William Schilling,
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
4. |
Thyroid HormoneTargeting the Vascular Smooth Muscle Cell |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 260-261
Irwin Klein,
Kaie Ojamaa,
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
5. |
Nuclear Factor-&kgr;B and Cell SurvivalIAPs Call for Support |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 262-264
Richard Lee,
Tucker Collins,
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
6. |
Function, Metabolic, and Flow Heterogeneity of the HeartThe View Is Getting Better |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 265-267
Robert Balaban,
Andrew Arai,
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
7. |
LDL Downregulates CYP51 in Porcine Vascular Endothelial Cells and in the Arterial Wall Through a Sterol Regulatory Element Binding Protein-2–Dependent Mechanism |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 268-274
Cristina Rodríguez,
José Martínez-González,
Sonia Sánchez-Gómez,
Lina Badimon,
Preview
|
PDF (1596KB)
|
|
摘要:
Abstract—Hypercholesterolemia is associated with endothelial dysfunction and atherosclerotic lesion formation. By mRNA–differential display analysis, we have identified lanosterol 14&agr;-demethylase (CYP51) as a gene highly regulated by native LDLs (nLDLs) in endothelial cells. CYP51 is a cytochrome P-450 enzyme involved in the postsqualene phases of cholesterol biosynthesis. CYP51 mRNA levels decrease in nLDL-treated cells in a dose- and time-dependent manner (9-fold after 24 hours with 180 mg of LDL cholesterol per deciliter), an effect that is blocked by cycloheximide. In parallel, sterol regulatory element (SRE) binding protein-2 (SREBP-2) expression falls (10-fold), without alteration in SREBP-1 level.N-Acetyl-leucyl-leucyl-norleucinal, which inhibits catabolism of the active form of SREBPs, abolished the effect of high concentrations of nLDL on CYP51 expression. Gel-shift assays performed with the SRE of thecyp51gene (cyp51-SRE) revealed a diminished SREBP-SRE interaction in LDL-treated cells. Moreover, nLDLs downregulate CYP51 promoter activity in transfection assays. Thus, atherogenic levels of nLDL downregulate endothelial CYP51 mRNA levels through a reduction in SRE–SREBP-2 interaction. Additionally, SREBP-2 and CYP51 mRNA levels are decreased in the arterial wall of hypercholesterolemic pigs. In summary, we have described for the first time, both in in vivo and in vitro systems, that CYP51 is expressed in the vascular wall and that it is downregulated together with SREBP-2 by high levels of nLDL. Because this transcription factor controls multiple cell lipid metabolism pathways, its regulation by nLDL could play a key role in lipid-mediated endothelial dysfunction.
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
8. |
Vasoactive Potential of the B1Bradykinin Receptor in Normotension and Hypertension |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 275-281
Irena Duka,
Ekaterina Kintsurashvili,
Irene Gavras,
Conrado Johns,
Margaret Bresnahan,
Haralambos Gavras,
Preview
|
PDF (582KB)
|
|
摘要:
Abstract—The B1type receptor of bradykinin (Bk B1R) is believed to be physiologically inert but highly inducible by inflammatory mediators and tissue damage. To explore the potential participation of the Bk B1R in blood pressure (BP) regulation, we studied mice with deleted Bk B2R gene with induced experimental hypertension, either salt-dependent (subtotal nephrectomy with 0.5% NaCl as drinking water) or renin/angiotensin-dependent (renovascular 2-kidney–1-clip). Compared with the wild-type controls, the B2R gene knockout mice had a higher baseline BP (109.7±1.1 versus 101.1±1.3 mm Hg,P=0.002), developed salt-induced hypertension faster (in 19.3±2.3 versus 27.7±2.4 days,P=0.024), and had a more severe end point BP (148±3.7 versus 133±3.1 mm Hg,P<0.05). On the contrary, renovascular hypertension developed to the same extent (149.7±4.3 versus 148±3.6 mm Hg) and in the same time frame (14±2.2 versus 14±2.1 days). A bolus infusion of a selective B1R antagonist at baseline produced a significant hypertensive response (by 11.4±2 mm Hg) in the knockout mice only. Injection of graded doses of a selective B1R agonist produced a dose-dependent hypotensive response in the knockout mice only. Assessment of tissue expression of B1R and B2R genes by reverse transcription–polymerase chain reaction techniques revealed significantly higher B1R mRNA levels in the B2R knockout mice at all times (normotensive baseline and hypertensive end points). At the hypertensive end points, there was always an increase in B1R gene expression over the baseline values. This increase was significant in cardiac and renal tissues in all hypertensive wild-type mice but only in the clipped kidney of the renovascular knockout mice. The B2R gene expression in the wild-type mice remained unaffected by experimental manipulations. These results confirm the known vasodilatory and natriuretic function of the Bk B2R; they also indicate that in its absence, the B1R can become upregulated and assume some of the hemodynamic properties of the B2R. Furthermore, they indicate that experimental manipulations to produce hypertension also induce upregulation of the B1R, but not the B2R, in cardiac and renal tissues.
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
9. |
xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-&kgr;BNew Survival Pathways Disabled by Caspase-Mediated Cleavage During Apoptosis of Human Endothelial Cells |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 282-290
Bodo Levkau,
Kyle Garton,
Nicola Ferri,
Kerstin Kloke,
Jerzy-Roch Nofer,
Hideo Baba,
Elaine Raines,
Günter Breithardt,
Preview
|
PDF (5190KB)
|
|
摘要:
Abstract—Survival of human vascular endothelial cells depends on their ability to activate the transcription factor nuclear factor-&kgr;B (NF-&kgr;B), a regulator of antiapoptotic genes, such as the X chromosome–linked inhibitor of apoptosis protein (xIAP). In the present study, we demonstrated expression of xIAP in the endothelial lining of normal human arteries and veins and elevated levels in highly malignant human endothelial tumors. Using retroviral infection of human endothelial cells, we identified two novel survival mechanisms mediated by xIAP in endothelial cells. First, xIAP can activate the transcription factor NF-&kgr;B, a known survival factor for human endothelial cells. This positive feedback loop induced by xIAP is mediated via phosphorylation and sustained degradation of inhibitor (I) &kgr;B&agr;. Second, xIAP can inhibit cell proliferation via downregulation of cyclins A and D1 and induction of the cyclin-dependent kinase inhibitors p21Cip1/Waf1and p27Kip1. Cleavage of xIAP by caspases during endothelial cell apoptosis disables both of these biological functions of xIAP. Thus, caspase-mediated cleavage of xIAP interrupts a positive regulatory cytoprotective loop between NF-&kgr;B and xIAP and increases the vulnerability of the cell to apoptosis by releasing it from an xIAP-mediated quiescent state.
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
10. |
AKAP-Mediated Targeting of Protein Kinase A Regulates Contractility in Cardiac Myocytes |
|
Circulation Research: Journal of the American Heart Association,
Volume 88,
Issue 3,
2001,
Page 291-297
Mary Fink,
Daniel Zakhary,
Julie Mackey,
Russell Desnoyer,
Carolyn Apperson-Hansen,
Derek Damron,
Meredith Bond,
Preview
|
PDF (522KB)
|
|
摘要:
Abstract—Compartmentalization of cAMP-dependent protein kinase A (PKA) by A-kinase anchoring proteins (AKAPs) targets PKA to distinct subcellular locations in many cell types. However, the question of whether AKAP-mediated PKA anchoring in the heart regulates cardiac contractile function has not been addressed. We disrupted AKAP-mediated PKA anchoring in cardiac myocytes by introducing, via adenovirus-mediated gene transfer, Ht31, a peptide that binds the PKA regulatory subunit type II (RII) with high affinity. This peptide competes with endogenous AKAPs for RII binding. Ht31P (a proline-substituted derivative), which does not bind RII, was used as a negative control. We then investigated the effects of Ht31 expression on RII distribution, Ca2+cycling, cell shortening, and PKA-dependent substrate phosphorylation. By confocal microscopy, we showed redistribution of RII from the perinuclear region and from periodic transverse striations in Ht31P-expressing cells to a diffuse cytosolic localization in Ht31-expressing cells. In the presence of 10 nmol/L isoproterenol, Ht31-expressing myocytes displayed an increased rate and amplitude of cell shortening and relaxation compared with control cells (uninfected and Ht31P-expressing myocytes); with isoproterenol stimulation we observed decreased time to 90% decline in Ca2+but no significant difference between Ht31-expressing and control cells in the rate of Ca2+cycling or amplitude of the Ca2+transient. The increase in PKA-dependent phosphorylation of troponin I and myosin binding protein C on isoproterenol stimulation was significantly reduced in Ht31-expressing cells compared with controls. Our results demonstrate that, in response to &bgr;-adrenergic stimulation, cardiomyocyte function and substrate phosphorylation by PKA is regulated by targeting of PKA by AKAPs.
ISSN:0009-7330
出版商:OVID
年代:2001
数据来源: OVID
|
|